XML 61 R34.htm IDEA: XBRL DOCUMENT v3.20.1
Shareholders' Equity (Tables)
12 Months Ended
Dec. 31, 2019
Stockholders' Equity Note [Abstract]  
Schedule of assumptions used in estimation of grant date fair value of RSUs
The Company recognizes compensation expenses on these RSUs based on estimated grant date fair value, with the following assumptions:

   
2014
   
2015
   
2017
 
Expected dividend yield
   
2.06
%
   
3.22
%
   
2.68
%
Termination rate
   
4.35
%
   
0
%
   
1.74
%
                         
Schedule of assumptions used in estimation of grant date fair value of options
The Company recognizes compensation expenses on these options based on estimated grant date fair value using the Binomial option-pricing model with the following assumptions:
 
Average Risk-free interest rate (a)
   
2.08
%
Expected dividend yield
   
2.09
%
Average expected volatility (b)
   
53.01
%
Termination rate
   
9
%
Suboptimal factor (c)
   
3.4
 

(a)
Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
(b)
Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
(c)
Suboptimal factor represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal factor of the Company and similar companies.
   

 

 

 

 


The Company recognizes compensation expenses on these options based on estimated grant date fair value using the Binomial option-pricing model with the following assumptions:

 

 
Average Risk-free interest rate (a)
   
1.58
%
Expected dividend yield
   
2.42
%
Average expected volatility (b)
   
47.90
%
Termination rate
   
9
%
Suboptimal factor (c)
   
3.32
 
 
(a)
Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
(b)
Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
(c)
Suboptimal factor represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal factor of the Company and similar companies.
   

 

 

 

The Company recognizes compensation expenses on these options based on estimated grant date fair value using the Binomial option-pricing model with the following assumptions:

 

 
Average Risk-free interest rate (a)
   
2.35
%
Expected dividend yield
   
2.42
%
Average expected volatility (b)
   
43.71
%
Termination rate
   
9
%
Suboptimal factor (c)
   
3.28
 

(a)
Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
(b)
Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
(c)
Suboptimal factor represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal factor of the Company and similar companies.
   

 

 
 
 

The Company recognizes compensation expenses on these options based on estimated grant date fair value using the Binomial option-pricing model with the following assumptions:

 


Average Risk-free interest rate (a)
   
2.92
%
Expected dividend yield
   
0.0
%
Average expected volatility (b)
   
45.13
%
Termination rate
   
9
%
Suboptimal factor (c)
   
3.2
 

(a)
Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
(b)
Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
(c)
Suboptimal factor represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal factor of the Company and similar companies.
   
 
 
 

The Company recognizes compensation expenses on these options based on estimated grant date fair value using the Binomial option-pricing model with the following assumptions:

 


Average Risk-free interest rate (a)
   
2.55
%
Expected dividend yield
   
0.0
%
Average expected volatility (b)
   
44.62
%
Termination rate
   
9
%
Suboptimal factor (c)
   
3.18
 

(a)
Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
(b)
Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
(c)
Suboptimal factor represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal factor of the Company and similar companies.
Stock Option Summary
The following table summarizes information regarding stock options as at December 31, 2019:
 
     
Options outstanding
   
Options exercisable
 
           
Weighted average
         
Weighted average
 
           
remaining
         
remaining
 
Exercise price
   
Number
   
contractual life
   
Number
   
contractual life
 
US$
   
of options
   
(in years)
   
of options
   
(in years)
 
                           
15.28
     
6,575
     
0.7
     
6,575
     
0.7
 
                                   
26.91
     
19,332
     
3.6
     
19,332
     
3.6
 
                                   
33.27
     
19,706
     
6.3
     
19,706
     
6.3
 
                                   
28.38
     
72,198
     
4.4
     
72,198
     
4.4
 
                                   
39.62
     
101,838
     
5.1
     
101,838
     
5.1
 
                                   
36.11
     
116,257
     
6.3
     
-
     
-
 
                                   
33.83
     
129,341
     
7.1
     
-
     
-
 
                                   
       
465,247
             
219,649
         
Stock Option Activity
The stock option activity under the abovementioned plans is as follows:
 
               
Weighted
 
         
Weighted
   
average
 
   
Number
   
average
   
grant date
 
   
of options
   
exercise price
   
fair value
 
         
US$
   
US$
 
                   
Balance at January 1, 2017
   
266,005
             
                     
Granted
   
119,925
     
39.62
     
11.89
 
Exercised
   
(124,918
)
   
21.46
     
8.46
 
Forfeited
   
(11,101
)
   
33.18
     
10.87
 
                         
Balance at December 31, 2017
   
249,911
                 
                         
Granted
   
137,010
     
36.11
     
14.71
 
Exercised
   
(9,674
)
   
28.02
     
9.94
 
Forfeited
   
(11,752
)
   
36.73
     
13.05
 
                         
Balance at December 31, 2018
   
365,495
                 
                         
Granted
   
141,928
     
33.83
     
13.35
 
Exercised
   
(5,500
)
   
28.09
     
10.03
 
Forfeited
   
(36,676
)
   
35.88
     
13.50
 
                         
Balance at December 31, 2019
   
465,247
                 
Exercisable at December 31, 2019
   
219,649
                 
Schedule of Restricted Share Units activity
The Restricted Share Units activity under the abovementioned plans is as follows:
 
         
Weighted
 
   
Number of
   
average
 
   
Restricted
   
grant date
 
   
Share Units
   
fair value
 
         
US$
 
             
Balance at January 1, 2017
   
43,000
       
               
Granted
   
78,000
     
34.90
 
Vested
   
(43,000
)
   
42.52
 
                 
Balance at December 31, 2017 and December 31, 2018
   
78,000
         
                 
Vested
   
(39,000
)
   
35.36
 
                 
Balance at December 31, 2019
   
39,000
         
Summary of Allocation of the Stock-Based Compensation Expenses
During 2017, 2018 and 2019, the Company recorded share-based compensation expenses. The following summarizes the allocation of the stock-based compensation expenses:
 
   
Year ended December 31
 
   
2017
   
2018
   
2019
 
   
US$ thousands
 
                   
Cost of sales
   
320
     
372
     
437
 
Research and development costs
   
832
     
953
     
900
 
Selling and marketing expenses
   
537
     
569
     
493
 
General and administrative expenses
   
736
     
530
     
525
 
                         
     
2,425
     
2,424
     
2,355